V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008252 | 280011712 | 1.77 | 106 | Neo-adjuvant (N) | 2015-12-07 | 2015-12-09 | DOXORUBICIN | null | null | 280026861 | DOXORUBICIN |
| 280008253 | 280011319 | 1.52 | 42 | Curative (C) | 2013-07-12 | 2013-08-26 | Cetuximab + Radiotherapy Maint | N | Y | 280026874 | CETUXIMAB + RT |
| 280008254 | 280011319 | null | 71 | Curative (C) | 2017-07-28 | 2017-10-07 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026874 | RMS 2005 TRIAL |
| 280008255 | 280005456 | 1.14 | 45.7 | Neo-adjuvant (N) | 2017-01-05 | 2017-04-02 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280026890 | IVA |
| 280008256 | 280005458 | 1.8 | null | null | 2014-04-13 | 2014-05-08 | Cetuximab + Radiotherapy Maint | 2 | Y | 280026891 | CETUXIMAB + RT |
| 280008257 | 280005459 | 1.58 | 17.7 | Palliative (P) | 2015-08-28 | 2015-08-28 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280026892 | PACLITAXEL |
| 280008258 | 280005460 | 1.66 | 77.25 | Palliative (P) | null | 2014-09-19 | Paclitaxel 7 day | N | N | 280026893 | PACLITAXEL |
| 280008259 | 280005461 | 1.76 | 90.9 | Neo-adjuvant (N) | null | 2013-09-11 | DOXORUBICIN | 02 | N | 280026893 | DOXORUBICIN |
| 280008260 | 280005463 | 1.82 | 84.8 | Palliative (P) | null | 2014-10-23 | Cetuximab + Radiotherapy Maint | N | N | 280026900 | CETUXIMAB + RT |
| 280008261 | 280005465 | 0 | 73.5 | Palliative (P) | 2016-01-09 | 2016-10-20 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280026900 | RMS 2005 TRIAL |
| 280008262 | 280005466 | 1.54 | 75 | Curative (C) | 2014-02-11 | 2014-04-15 | CETUXIMAB + RT | N | Y | 280026902 | CETUXIMAB + RT |
| 280008263 | 280005469 | 1.78 | 87 | Palliative (P) | null | 2017-10-11 | DOXORUBICIN | N | N | 280026903 | DOXORUBICIN |
| 280008264 | 280005469 | 1.8 | 78.2 | Curative (C) | 2017-03-01 | 2017-03-27 | Cisplatin 7 day | N | Y | 280026903 | CISPLATIN |
| 280008265 | 280008879 | 1.81 | 77.25 | Curative (C) | 2018-03-08 | 2018-03-09 | Ifosfamide PVI 1g/m2 14day | N | Y | 280026908 | IFOSFAMIDE |
| 280008266 | 280005471 | null | 85.3 | Curative (C) | null | 2017-01-09 | CARBOPLATIN + RT | Y | Y | 280026918 | CARBOPLATIN + RT |
| 280008267 | 280005472 | 1.68 | 108.8 | Neo-adjuvant (N) | 2016-02-29 | 2016-02-29 | Doxorubicin 75mg/m2 | 02 | N | 280026919 | DOXORUBICIN |
| 280008268 | 280005474 | 1.71 | 89 | Curative (C) | 2017-05-02 | 2017-06-27 | CETUXIMAB + RT | N | N | 280026919 | CETUXIMAB + RT |
| 280008269 | 280010522 | 1.58 | 54.35 | Curative (C) | null | 2016-01-18 | Cisplatin | N | Y | 280026921 | CISPLATIN |
| 280008270 | 280008882 | 1.57 | 103 | Curative (C) | null | 2014-01-09 | Cetuximab + Radiotherapy Maint | 2 | Y | 280026927 | CETUXIMAB + RT |
| 280008271 | 280008882 | 1.69 | 72.8 | Palliative (P) | 2015-02-16 | 2015-03-11 | Cisplatin | N | Y | 280026927 | CISPLATIN |
| 280008272 | 280008882 | 1.7 | null | Palliative (P) | 2014-03-11 | 2014-04-26 | Cetuximab + Radiotherapy Maint | null | null | 280026927 | CETUXIMAB + RT |
| 280008273 | 280005480 | 1.76 | 97.2 | Curative (C) | 2016-11-16 | 2017-03-27 | CARBOPLATIN + RT | N | N | 280026934 | CARBOPLATIN + RT |
| 280008274 | 280005481 | null | null | Neo-adjuvant (N) | 2013-03-19 | 2013-03-21 | DOXORUBICIN | N | N | 280026935 | DOXORUBICIN |
| 280008275 | 280005482 | null | 80 | null | 2016-06-12 | 2016-07-07 | Cisplatin | N | Y | 280026948 | CISPLATIN |
| 280008276 | 280005483 | 1.5 | 66.9 | Adjuvant (A) | 2013-12-24 | 2014-01-30 | Cetuximab + Radiotherapy Maint | Y | Y | 280026958 | CETUXIMAB + RT |
| 280008277 | 280005484 | 0 | 27.4 | null | 2016-03-13 | 2016-04-24 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026960 | IVA |
| 280008278 | 280005485 | 1.57 | 72.6 | Palliative (P) | 2013-04-28 | 2013-04-28 | Cisplatin 7 day | null | null | 280026961 | CISPLATIN |
| 280008279 | 280008886 | 1.63 | 72.6 | Palliative (P) | 2015-03-27 | 2015-04-16 | Ifosfamide | 02 | N | 280026967 | IFOSFAMIDE |
| 280008280 | 280008886 | 1.7 | 94 | Palliative (P) | null | 2014-11-29 | Cetuximab + Radiotherapy Maint | N | N | 280026967 | CETUXIMAB + RT |
| 280008281 | 280008886 | 0 | 68.9 | Curative (C) | 2013-04-24 | 2013-04-24 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026967 | IVA |
| 280008282 | 280005488 | null | 52.3 | Not known (9) | null | 2015-01-07 | Cisplatin | N | Y | 280026975 | CISPLATIN |
| 280008283 | 280008887 | 0.9 | 65 | null | 2015-09-19 | 2015-10-02 | CETUXIMAB + RT | Y | null | 280026976 | CETUXIMAB + RT |
| 280008284 | 280005489 | 1.8 | 65 | Palliative (P) | null | 2014-06-04 | Cisplatin 7 day | Y | N | 280026978 | CISPLATIN |
| 280008285 | 280005489 | 1.72 | 58.15 | null | 2017-09-19 | 2017-11-26 | Cetuximab + Radiotherapy Load | 2 | null | 280026978 | CETUXIMAB + RT |
| 280008286 | 280005490 | 1.88 | 61.6 | Palliative (P) | 2018-08-01 | 2018-08-12 | Ifosfamide | null | null | 280026991 | IFOSFAMIDE |
| 280008287 | 280005492 | 0.7 | 77.4 | Curative (C) | null | 2014-09-04 | Cetuximab + Radiotherapy Maint | null | null | 280026993 | CETUXIMAB + RT |
| 280008288 | 280005492 | null | 96.4 | Palliative (P) | 2017-05-08 | 2017-05-10 | STS Rhabdo RMS 2005 Vin Cyclo | null | N | 280026993 | RMS 2005 TRIAL |
| 280008289 | 280005493 | 1.82 | 77.4 | Palliative (P) | null | 2014-09-18 | Cetuximab + Radiotherapy Maint | 2 | N | 280026997 | CETUXIMAB + RT |
| 280008290 | 280005493 | 1.88 | null | Palliative (P) | null | 2016-03-28 | Ifosfamide | Y | N | 280026997 | IFOSFAMIDE |
| 280008291 | 280008891 | 1.7 | 77.25 | Palliative (P) | null | 2017-03-17 | PACLITAXEL | 01 | N | 280027001 | PACLITAXEL |
| 280008292 | 280005496 | 1.86 | 30.8 | Palliative (P) | 2015-09-11 | 2015-09-23 | Cetuximab + Radiotherapy Maint | 01 | N | 280027008 | CETUXIMAB + RT |
| 280008293 | 280005497 | null | 115.65 | Neo-adjuvant (N) | 2015-03-26 | 2015-04-05 | Doxorubicin 75mg/m2 | 02 | null | 280027010 | DOXORUBICIN |
| 280008294 | 280008892 | null | 92.4 | Adjuvant (A) | 2018-06-15 | 2018-08-06 | Cetuximab + Radiotherapy Maint | Y | N | 280027013 | CETUXIMAB + RT |
| 280008295 | 280005498 | null | null | Palliative (P) | null | 2013-12-17 | Cisplatin | N | Y | 280027016 | CISPLATIN |
| 280008296 | 280005498 | 1.63 | 70.1 | Palliative (P) | 2016-10-18 | 2016-10-18 | DOXORUBICIN | N | N | 280027016 | DOXORUBICIN |
| 280008297 | 280005499 | null | 78 | Palliative (P) | 2013-06-19 | 2013-06-19 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280027021 | RMS 2005 TRIAL |
| 280008298 | 280005499 | 0 | 16 | Curative (C) | 2014-04-24 | 2014-04-24 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280027021 | RMS 2005 TRIAL |
| 280008299 | 280005499 | 1.6 | null | Palliative (P) | null | 2015-04-01 | Cetuximab + Radiotherapy Maint | N | N | 280027021 | CETUXIMAB + RT |
| 280008300 | 280005500 | 1.65 | 25.5 | Palliative (P) | 2016-02-18 | 2016-02-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280027026 | PACLITAXEL |
| 280008301 | 280008895 | null | 54.7 | Adjuvant (A) | 2017-03-13 | 2017-03-20 | CARBOPLATIN + RT | 02 | Y | 280027031 | CARBOPLATIN + RT |